期刊文献+

血清松弛素与孕产妇盆底功能变化的关系 被引量:25

The relationship between serum concentration of relaxin and the pelvic floor function
暂未订购
导出
摘要 目的测定妊娠和产后不同时期的血清松弛素(relaxin,RLX)水平,以探讨孕产妇孕期和产后盆底功能变化的机制。方法选取健康孕产妇36例分别于孕晚期、产后6~8周、产后3~6个月测定其盆底肌肉综合肌力作为研究组,无分娩史、无盆底功能障碍性疾病(PFD)史的非妊娠女性20例作为对照组;应用酶联免疫吸附法检测不同时期的血清RLX水平;并行自制PFD问卷调查。结果妊娠晚期RLX水平明显高于产后两组及对照组(P<0.001),产后两组与对照组的血清RLX水平比较,差异无统计学意义(P=0.913);孕晚期血清RLX水平与孕晚期和产后盆底肌综合肌力呈负相关(r=-0.354、-0.415,P<0.05);孕晚期和产后两组有SUI症状者的RLX[(462.17±27.45)pg/ml、(466.00±24.91)、(458.00±27.80)pg/ml]水平高于无症状者[(427.00±31.51)pg/ml、(429.63±32.30)pg/ml、(433.20±33.05)pg/ml;P<0.05];孕晚期和产后两组的腰骶部酸痛者孕期血清RLX[(449.76±32.13)pg/ml、(450.48±32.55)pg/ml、(442.12±31.95)pg/ml]水平明显增高(P<0.05);产后6~8周和3~6个月阴道松弛者孕晚期血清RLX[(446.71±26.96)pg/ml;444.38±36.90)pg/ml]水平均较高。结论妊娠期出现盆底功能改变与体内激素的变化有关;孕期高水平的血清RLX可作用于盆底胶原组织,可能是孕期和产后PFD的病理机制之一。 Objective To detect the mechanisms of change of pelvic floor function and the etiopathogenisis of pelvic floor dysfunction(PFD).MethodsPelvic floor muscle strength was measured in 36 women in late pregnancy(group 1),6 to 8 weeks after labour(group 2)and 3 to 6 months after labour(group 3).20 nulliparous and nonfertile women acted as control(control group).Serum concentration of relaxin(RLX)in each group were detected by enzymelinked immunosorbent assay;and pelvic floor dysfunction questionnaire were fulfilled.ResultsConcentration of serum RLX in group 1 was significantly higher than that in group 2,group3 and control group(F=2 072.79,P0.001),and there were no significant difference between group 2,3 and control(F=0.092,P=0.913);the level of RLX in antepartum and early postpartum were negatively correlated with postpartum pelvic floor muscle strength(r=-0.354、-0.415,P0.05).There were significant impact of the concentrations of antepartum serum RLX on the symptom of SUI before delivery and early postpartum and the symptom of ache at waist and sacrum before delivery and early postpartum.ConclusionsThe high level serum of RLX during pregnancy affects the change of pelvic floor collagen,which may be one of the pathomechanisms of PFD.
出处 《中国妇产科临床杂志》 2011年第2期96-99,共4页 Chinese Journal of Clinical Obstetrics and Gynecology
基金 广东省医学科研基金立项资助课题(A2007338和A2008364) 广东省科技计划(2007B060401054)项目 国家自然科学基金面(81070459)项目资助
关键词 盆底 肌力 盆底功能障碍性疾病 血清松弛素 pelvic floor muscle strength pelvic floor dysfunction serum relaxin
  • 相关文献

参考文献17

  • 1胡承阅.松弛素、松弛素样因子在生殖过程中的作用[J].国外医学(计划生育分册),2002,21(2):85-88. 被引量:9
  • 2程丹玲,朱辉.松弛素样因子与生殖[J].生殖医学杂志,2005,14(3):182-184. 被引量:4
  • 3Kristiansson P, Samuelsson E, Schoultz B, et al. Reproductive hormones and stress urinary incontinence in pregnancy. Acta Obstet Gynecol Scand, 2001, 80: 1125- 1130.
  • 4Laycock J, Haslam J. Therapeutic management of incontinence and pelvic pain. London: Springer- Vartag, 2002: 45- 49.
  • 5Petersen LK, Vogel I, Agger AO, et al. Variations in serurn relaxin (Hrlx- 2) coneentrations during human pregnan- cy. Acta Obstet Gynecol Scand, 1995, 74:251 - 256.
  • 6Weiss G, Goldsmith LT. Meehnisms of relaxin - mediated pre- mature birth. Ann NY Acad Sci, 2005, 1041.. 345 - 350.
  • 7Bryant GD. Relaxin. North Holand: Elsevier, 1981: 369.
  • 8Bergfelt DR, Steinetz BG, Dunn JE, et al. Validation of a homologous canine relaxin radioimmunoassay and application with pregnant and non - pregnant Northern fur seals. Gen Comp Endocrinol, 2010, 165: 19-24.
  • 9Haning RV, Steinetz BG, Weiss G. Elevated serum relaxin levels in multiple pregnancy after menotropin treatment. Obstet Gynecol, 1985, 66: 42-45.
  • 10Bell RJ, Sutton B, Eddiem LW, et al. Relaxin levelsin antenatal patients following in vitro fertilization. Fertil Steril, 1989, 52:85 - 87.

二级参考文献44

  • 1Adham IM, Burkhardt E, Banahmed M, et al. Cloning of a cDNA for a novel insulin-like peptide of the testicular Leydig cells [J]. Biol Chem,1993,268(35) :26668-26672.
  • 2Overbeek PA, Gorlov IP, Sutherland RW, et al. A transgenic insertion causing cryptorchidism in mice [J]. Genesis, 2001,30 (1):26-35.
  • 3Truong A, Bogatcheva NV, Schelling C, et al. Isolation and expression analysis of the canine insulin-like factor 3 gene[J]. Bio Reprod,2003, 69(5): 1658-1664.
  • 4Koskimies P,Levakket J,Sipila P, et al. Murine relaxin-like factor promoter: functional characterization and regulation by transcription factor 1 and DAX-1 [J]. Endocrinology, 2002,143 (3):909-919.
  • 5Barnberger AM, Ivell R, Balvers M, et al. Relaxin-like factor (RLF): a new specific marker for Leydig cells in the ovary[J].Gynecol Pathol, 1999,18(2): 163-168.
  • 6Balvers M, Spiess AN, Domagalski R,et al. Relaxin-like factor as a marker of differentiation in the mouse testis and ovary[J]. Endocrinology,1998, 139(6): 2960-2970.
  • 7Zarreh-Hoshyari-Khah MR, Einspanier A, Ivell R. Differential splicing and expression of the relaxin-like factor gene in reproductive tissues of the marmoset monkey[J]. Biol Reprod, 1999, 60(2):445-453.
  • 8Bathgate R, Moniac N, Bartlick B,et al. Expression and regulation of relaxin-like factor gene transcripts in the bovine ovary: differentiation-dependent expression in theca cell cultures[J]. Biol Reprod, 1999,61 (4): 1090-1098.
  • 9Irving-Rodgers HF, Bathgate RAD, Ivell R,et al. Dynamic changes in the expression of relaxin-like factor (INSL3), cholesterol side-chain cleavage cytochrome P450, and 3 β3-hydroxysteroid dehydrogenase in bovine ovarian follicles during growth and atresia [J]. Biol Reprod, 2002, 66(4) :934-943.
  • 10Nef S, Parada LF. Cryptorchidism in mice mutant for INSL3[J].Nat Genet,1999,22(3) :295-299.

共引文献9

同被引文献250

引证文献25

二级引证文献264

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部